BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19330729)

  • 1. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
    Oussalah A; Laurent V; Bruot O; Guéant JL; Régent D; Bigard MA; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1135-44. PubMed ID: 21039675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prohepcidin levels in chronic inflammatory bowel diseases.
    Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
    J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis.
    Paosong S; Narongroeknawin P; Pakchotanon R; Asavatanabodee P; Chaiamnuay S
    Int J Rheum Dis; 2015 Mar; 18(3):352-9. PubMed ID: 25469944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
    Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
    Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
    Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.
    Gaïni S; Koldkjaer OG; Pedersen C; Pedersen SS
    Crit Care; 2006; 10(2):R53. PubMed ID: 16569262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery.
    Jebali MA; Hausfater P; Abbes Z; Aouni Z; Riou B; Ferjani M
    Anesthesiology; 2007 Aug; 107(2):232-8. PubMed ID: 17667566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis.
    Riché FC; Cholley BP; Laisné MJ; Vicaut E; Panis YH; Lajeunie EJ; Boudiaf M; Valleur PD
    Surgery; 2003 Mar; 133(3):257-62. PubMed ID: 12660636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin and the early diagnosis of infective endocarditis.
    Mueller C; Huber P; Laifer G; Mueller B; Perruchoud AP
    Circulation; 2004 Apr; 109(14):1707-10. PubMed ID: 15066945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis.
    Ruiz-Alvarez MJ; García-Valdecasas S; De Pablo R; Sanchez García M; Coca C; Groeneveld TW; Roos A; Daha MR; Arribas I
    J Intensive Care Med; 2009; 24(1):63-71. PubMed ID: 19054806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin in the assessment of bacteraemia in emergency department patients: results of a large retrospective study.
    Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2015 Nov; 52(Pt 6):654-9. PubMed ID: 25575698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and C-reactive protein serum levels after hematopoietic stem-cell transplant.
    Azarpira N; Ramzi M; Aghdaie M; Daraie M
    Exp Clin Transplant; 2009 Jun; 7(2):115-8. PubMed ID: 19715516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.